These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15587001

  • 1. A preventive ethics approach to methadone maintenance programmes.
    Townshend PL, Sellman JD, Coverdale JH.
    N Z Bioeth J; 2001 Oct; 2(3):7-13. PubMed ID: 15587001
    [Abstract] [Full Text] [Related]

  • 2. Methadone maintenance treatment: outcomes from the Otago methadone programme.
    Dore GM, Walker JD, Paice JR, Clarkson S.
    N Z Med J; 1999 Nov 26; 112(1100):442-5. PubMed ID: 10678242
    [Abstract] [Full Text] [Related]

  • 3. Dependent opioid users assessed for methadone treatment in Otago: patterns of drug use.
    Dore GM, Hargreaves G, Niven BE.
    N Z Med J; 1997 May 09; 110(1043):162-5. PubMed ID: 9196499
    [Abstract] [Full Text] [Related]

  • 4. Ethical aspects of substance abuse and intervention: reflecting on methadone maintenance in New Zealand.
    Kermack A.
    N Z Bioeth J; 2001 Oct 09; 2(3):14-22. PubMed ID: 15587002
    [Abstract] [Full Text] [Related]

  • 5. Challenging perspectives on MMT. Response.
    Benton D.
    N Z Bioeth J; 2001 Oct 09; 2(3):33-4. PubMed ID: 15587006
    [No Abstract] [Full Text] [Related]

  • 6. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May 09; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 7. Informed consent and provider-patient relationships in rehabilitation medicine.
    Caplan AL.
    Arch Phys Med Rehabil; 1988 May 09; 69(5):312-7. PubMed ID: 3365111
    [Abstract] [Full Text] [Related]

  • 8. Barriers to, and incentives for, the transfer of opioid-dependent people on methadone maintenance treatment from secondary care to primary health care.
    Sheridan J, Goodyear-Smith F, Butler R, Wheeler A, Gohns A.
    Drug Alcohol Rev; 2008 Mar 09; 27(2):178-84. PubMed ID: 18264879
    [Abstract] [Full Text] [Related]

  • 9. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA, McNeil DA, Maloff B, Mutasingwa D, Wu M, Ford C, Tough SC.
    Obes Rev; 2006 Feb 09; 7 Suppl 1():7-66. PubMed ID: 16371076
    [Abstract] [Full Text] [Related]

  • 10. Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire.
    Deering D, Frampton C, Horn J, Sellman D, Adamson S, Potiki T.
    Drug Alcohol Rev; 2004 Sep 09; 23(3):273-80. PubMed ID: 15370006
    [Abstract] [Full Text] [Related]

  • 11. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services.
    Moran L, Keenan E, Elmusharaf K.
    BMC Health Serv Res; 2018 Nov 29; 18(1):911. PubMed ID: 30497467
    [Abstract] [Full Text] [Related]

  • 12. Autonomy in medical ethics after O'Neill.
    Stirrat GM, Gill R.
    J Med Ethics; 2005 Mar 29; 31(3):127-30. PubMed ID: 15738430
    [Abstract] [Full Text] [Related]

  • 13. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
    Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L.
    Drug Alcohol Depend; 2009 Nov 01; 105(1-2):9-15. PubMed ID: 19608355
    [Abstract] [Full Text] [Related]

  • 14. A special type of 'hard-to-reach' patient: experiences of pregnant women on methadone.
    Calvin C, Moriarty H.
    J Prim Health Care; 2010 Mar 01; 2(1):61-9. PubMed ID: 20690404
    [Abstract] [Full Text] [Related]

  • 15. Methadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-up.
    Rhodin A, Grönbladh L, Nilsson LH, Gordh T.
    Eur J Pain; 2006 Apr 01; 10(3):271-8. PubMed ID: 15972261
    [Abstract] [Full Text] [Related]

  • 16. The impact of substitution treatment in prisons--a literature review.
    Stallwitz A, Stöver H.
    Int J Drug Policy; 2007 Dec 01; 18(6):464-74. PubMed ID: 18061872
    [Abstract] [Full Text] [Related]

  • 17. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006 Dec 01; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR, Lea T, Sheridan J.
    Int J Drug Policy; 2008 Dec 01; 19(6):450-8. PubMed ID: 18359216
    [Abstract] [Full Text] [Related]

  • 19. Improvements in retention rates and changes in client group with methadone maintenance streaming.
    White JM, Ryan CF, Ali RL.
    Drug Alcohol Rev; 1996 Mar 01; 15(1):83-8. PubMed ID: 16203355
    [Abstract] [Full Text] [Related]

  • 20. Development of a brief treatment instrument for routine clinical use with methadone maintenance treatment clients: the methadone treatment index.
    Deering DE, Sellman JD, Adamson SJ, Horn J, Frampton CM.
    Subst Use Misuse; 2008 Mar 01; 43(11):1666-80. PubMed ID: 18752159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.